NOS3 and endothelial dysfunction: Since ADMA acts on vascular function by inhibiting eNOS, it is feasible to suggest that higher ADMA levels would inhibit NO production, resulting in vasoconstriction, hypertension, immune dysfunction and ultimate endothelial dysfunction in CKD [29].